N. Papaleo

Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes

L. Colomo, L. Arenillas, M. López-Guerra, 2018, Journal of Clinical Pathology.

MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.

E. Campo, E. Haralambieva, M. Salido, 2022, Archives of pathology & laboratory medicine.

Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas

L. Colomo, A. Salar, L. Arenillas, 2021, Virchows Archiv.

LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas

A. López-Guillermo, A. Ferrer, L. Colomo, 2017, The American journal of surgical pathology.

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

L. Colomo, A. Salar, M. Salido, 2020, Cancers.

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.

A. Salar, L. Colomo, M. Andrade-Campos, 2021, Thrombosis research.

Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.

L. Colomo, F. Climent, M. Salido, 2023, Virchows Archiv : an international journal of pathology.